Human Erbb2-induced Erk Activity Robustly Stimulates Cycling and Functional Remodeling of Rat and Human Cardiomyocytes
N. Strash, S. DeLuca, G. Janer Carattini, S. C. Heo, R. Gorsuch, N. Bursac
Abstract
Multiple mitogenic pathways capable of promoting mammalian cardiomyocyte (CM) proliferation have been identified as potential candidates for functional heart repair following myocardial infarction. However, it is unclear whether the effects of these mitogens are species-specific and how they directly compare in the same cardiac setting. Here, we examined how CM-specific lentiviral expression of various candidate mitogens affects human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) and neonatal rat ventricular myocytes (NRVMs) in vitro. In 2D-cultured CMs from both species, and in highly mature 3D-engineered cardiac tissues generated from NRVMs, a constitutively-active mutant form of the human gene Erbb2 (cahErbb2) was the most potent tested mitogen. Persistent expression of cahErbb2 induced CM proliferation, sarcomere loss, and remodeling of tissue structure and function, which were attenuated by small molecule inhibitors of Erk signaling. These results suggest transient activation of Erbb2/Erk axis in cardiomyocytes as a potential strategy for regenerative heart repair.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- BRAF-V600E-Mediated Erk Activation Promotes Sustained Cell Cycling and Broad Transcriptional Changes in Neonatal Cardiomyocytes
- ERBB2 drives YAP activation and EMT-like processes during cardiac regeneration
Alla Aharonov, Avraham Shakked, … Eldad Tzahor·Nature Cell BiologyPeer-reviewed·Oct 12, 2020
- Pharmacologically inducing regenerative cardiac cells by small molecule drugs
- In situ maturated early-stage human induced pluripotent stem cell-derived cardiomyocytes improve cardiac function by enhancing segmentary contraction in infarcted rats
D. Biagi, E. T. Fantozzi, … R. Dariolli·bioRxiv·Mar 9, 2021
- Robust Myocardial Regeneration After Selective Cardiomyocyte Loss Is Driven by Cardiac Stem Cell Activation Through the miR-221-p57 Axis
Eleonora Cianflone, Fabiola Marino, … Daniele Torella·bioRxiv·Jul 13, 2026
- MCM2 mediates post-MI cardioprotection by promoting the pro-angiogenic cardiosome signaling
Perwez Alam, Wei Chieh Huang, … Onur Kanisicak·bioRxiv·Dec 12, 2024